Cuba encouraged by early trials of homegrown COVID-19 vaccine

Cuba encouraged by early trials of homegrown COVID-19 vaccine

Channel NewsAsia - World·2021-06-20 11:02

HAVANA: Cuba's Soberana 2 vaccine candidate has shown 62 per cent efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday (Jun 19), citing preliminary data from late-phase trials.

Cuba, whose biotech sector has exported vaccines for decades, has five vaccine candidates in clinical trials, of which two - Soberana 2 and Abdala - are in late-phase trials.

……

Read full article on Channel NewsAsia - World

Health News International